In line with a dual role for BDP1 dependent on the mutational profile of the cancer, we recognize that ovarian cancer cells depend on MYC for maintaining their oncogenic growth and is amplified in 30–60% of all ovarian cancers.66 Here, MYC is linked to ovarian cancer.